In 2024, UAB Avelit Pharma had revenue of 93.8 thousand EUR and profit of 30.8 thousand EUR.
| year | 2024Latest |
|---|---|
Revenue | 93,8k € |
Profit | 30,8k € |
Assets | - |
Liabilities | - |
Equity | - |
Employees | - |
Overall rating | B72/100 |
Financial health | 65/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity |
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 2 years | 83 - 85 | 1% | |
Net revenue |
| Description | Registered |
|---|---|
| CEO (Male) |
UAB Avelit Pharma is located at Vilnius, Laisvės pr. 60-1107, LT-05120, LT-LT-05120.
In 2024, UAB Avelit Pharma had revenue of 93 809 EUR and profit of 30 797 EUR. View full financial report →
The shareholders of UAB Avelit Pharma include 1 Lithuanian legal entities. View ownership details →
Yes, UAB Avelit Pharma is registered as an active VAT payer with VAT number LT100017000218.
UAB Avelit Pharma was founded on February 9, 2024. The company has been operating for 2 years.
| 50/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
Positive profit | |
Incomplete reports | |
| 93 809,00 € |
50 - 54 |
40% |
Profit | 30 797,00 € | 1 - 5 | 98% |
Profitability | 32.8% | - | 75% |
Registered capital | 1000,00 € | - | 10% |
Annual financial report for 2024.
Registered in the Lithuanian register of legal entities.